Notably, HMGCS2 inhibition reduced ketone body concentrations, indicating that HMGCS2 knockdown attenuated cynaroside’s therapeutic effect on ketone body overproduction in NASH-T2DM C57BL/6J mice. This evidence concerns the gene HMGCS2 and type 2 diabetes mellitus.